SPONSOR
Institute for Molecular Medicine
Total Trials
1
Recruiting
1
Phases
Phase 1
Institute for Molecular Medicine is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Alzheimer Disease, Preclinical Alzheimer's Disease.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Institute for Molecular Medicine
How many clinical trials has Institute for Molecular Medicine sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Institute for Molecular Medicine, of which 1 are actively recruiting participants. These trials cover conditions including Alzheimer Disease, Preclinical Alzheimer's Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Institute for Molecular Medicine research focus on?
Institute for Molecular Medicine clinical trials span Alzheimer Disease, Preclinical Alzheimer's Disease. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Institute for Molecular Medicine clinical trial?
To participate in a Institute for Molecular Medicine trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Institute for Molecular Medicine trials with current recruitment status updated daily.
Clinical Trials by Institute for Molecular Medicine
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology